Cambria Biosciences

Cambria Pharmaceuticals is focused on discovering innovative treatments for serious and progressively disabling neurological disorders. The company exploits recent discoveries in the genetic basis of these disorders to engineer novel disease models and identify first-in-class disease-modifying compounds. Cambria leverages collaborative relationships with academic institutions and patient-focused foundations to advance its programs in ALS (Lou Gehrig's disease) and other serious neurological diseases.